Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bivalirudin: the relevance in today's interventional practice.

× No keyword cloud information.

16 in total

1. A second look at bivalirudin.

Authors: E M Antman; E Braunwald
Journal: Am Heart J Date: 2001-12 Impact factor: 4.749

Review 2. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice.

Authors: Brendan J Doyle; Charanjit S Rihal; Dennis A Gastineau; David R Holmes
Journal: J Am Coll Cardiol Date: 2009-06-02 Impact factor: 24.094

3. Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention.

Authors: Jeremy A Rassen; Murray A Mittleman; Robert J Glynn; M Alan Brookhart; Sebastian Schneeweiss
Journal: Eur Heart J Date: 2009-11-25 Impact factor: 29.983

4. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention.

Authors: Freek W A Verheugt; Steven R Steinhubl; Martial Hamon; Harald Darius; Philippe Gabriel Steg; Marco Valgimigli; Steven P Marso; Sunil V Rao; Anthony H Gershlick; A Michael Lincoff; Roxana Mehran; Gregg W Stone
Journal: JACC Cardiovasc Interv Date: 2011-02 Impact factor: 11.195

5. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.

Authors: J Fuchs; C P Cannon
Journal: Circulation Date: 1995-08-15 Impact factor: 29.690

6. Bivalirudin during primary PCI in acute myocardial infarction.

Authors: Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Ajay J Kirtane; Helen Parise; Roxana Mehran
Journal: N Engl J Med Date: 2008-05-22 Impact factor: 91.245

7. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.

Authors: Kenneth W Mahaffey; Bruce E Lewis; Nancy M Wildermann; Scott D Berkowitz; Renee M Oliverio; Mark A Turco; Yoseph Shalev; Peter Ver Lee; Jay H Traverse; A Ralph Rodriguez; E Magnus Ohman Ohman; Robert A Harrington; Robert M Califf
Journal: J Invasive Cardiol Date: 2003-11 Impact factor: 2.022

8. Safety and efficacy of bivalirudin with glycoprotein IIb/IIIa for high-risk percutaneous coronary intervention.

Authors: Niteen V Deshpande; Rebecca Pratiti; Parag Admane; Debabrata Mukherjee; Harshawardhan M Mardikar
Journal: Indian Heart J Date: 2012-07-27

9. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.

Authors: Gregg W Stone; Harvey D White; E Magnus Ohman; Michel E Bertrand; A Michael Lincoff; Brent T McLaurin; David A Cox; Stuart J Pocock; James H Ware; Frederick Feit; Antonio Colombo; Steven V Manoukian; Alexandra J Lansky; Roxana Mehran; Jeffrey W Moses
Journal: Lancet Date: 2007-03-17 Impact factor: 79.321

10. Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry.

Authors: Ashok Seth; Nakul Sinha; Keyur Parikh; Tejas Patel; M S Hiremath; A B Mehta; Praveen Chandra; Brian Pinto; K K Sethi; Sengottuvelu Sengottuvelu
Journal: Indian Heart J Date: 2008 Jul-Aug